Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali 10-jild 5-son (2025)

ANALYSIS OF TREATMENT RESULTS FOR PATIENTS WITH RECTAL METASTIC CANCER

ИСЛАМОВ Хуршид Джамшидович

Manbada oʻqish PDF

Annotatsiya

This study was conducted on the basis of the Department of Coloproctology of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology in Tashkent. The study included 78 patients with colorectal cancer (CRC) of stage II-IV of the disease who underwent surgical treatment in the department of Coloproctology of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology. Performing cytoreductive surgery on patients with colorectal cancer with liver metastases may help improve the quality of life of these patients in the long term.

колоректальный рак, метастаз, циторедуктивная операция, полихимиотерапияcolorectal cancer, metastases, cytoreductive surgery, polychemotherapyколоректал рак, метастаз, циторедуктив операция, полихимиотерапия.

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.

Iqtibos olish

APA 7
ИСЛАМОВ Хуршид Джамшидович (2025). ANALYSIS OF TREATMENT RESULTS FOR PATIENTS WITH RECTAL METASTIC CANCER. Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali, 10(5).
GOST R 7.0.5
ИСЛАМОВ Хуршид Джамшидович ANALYSIS OF TREATMENT RESULTS FOR PATIENTS WITH RECTAL METASTIC CANCER // Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali. 2025. Т. 10. № 5.
BibTeX
@article{джамшидович2025,
  author  = {ИСЛАМОВ Хуршид Джамшидович},
  title   = {ANALYSIS OF TREATMENT RESULTS FOR PATIENTS WITH RECTAL METASTIC CANCER},
  journal = {Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali},
  year    = {2025},
  volume  = {10},
  number  = {5}
}
RIS
TY  - JOUR
AU  - ИСЛАМОВ Хуршид Джамшидович
TI  - ANALYSIS OF TREATMENT RESULTS FOR PATIENTS WITH RECTAL METASTIC CANCER
JO  - Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
PY  - 2025
VL  - 10
IS  - 5
ER  -